World Cancer Research Day With Dr. Thomas Abrams
Keira Smith
Expert Analysis
Oncology Data Advisor™ · World Cancer Research Day With Dr. Thomas Abrams On World Cancer Research Day, Dr. Thomas Abrams of Harvard Medical School discussed his career as a gastrointestinal cancer researcher and the progress that has been made in this field.
Perspectives on Metastatic and Castration-Resistant Prostate Cancer: A Discussion with Ulka Vaishampayan, MD
Selma Khenissi, MPS
Expert Analysis
Selma Khenissi, MPS: Hello, welcome to Oncology Data Advisor. I'm Selma Khenissi from i3 Health. In honor of prostate cancer awareness month, we are here today with Dr. Ulka Vaishampayan, who will be discussing issues surrounding prostate cancer. Welcome. Ulka Vaishampayan, MD: Thank you for having me on this interview. I would like to bring our pr...
Improving Patient Experiences in Multiple Myeloma With Tiffany Richards, PhD, ANP-BC
Sarah Williams, MAT
Expert Analysis
At the Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit in Los Angeles, California, Oncology Data Advisor spoke with Tiffany Richards, PhD, ANP-BC, Advanced Practice Nurse at MD Anderson Cancer Center, about strategies for optimizing patient experiences during multiple myeloma treatment. Dr. Richards discusses the challeng...
World Cancer Research Day With Dr. Thomas Abrams
Keira Smith
Expert Analysis
Thomas Abrams, MD. On World Cancer Research Day, Dr. Thomas Abrams, Assistant Professor of Medicine at Harvard Medical School and the new Editor in Chief of Oncology Data Advisor, discusses his career as a gastrointestinal cancer researcher, the recent advancements that have been made, and the progress that is on the horizon in this field. 
Optimizing Treatment Planning for Immune Thrombocytopenia: A Conversation With Allison Imahiyerobo, APN
Keira Smith
Expert Analysis
· In this podcast, Allison Imahiyerobo, APN, of Hematology Oncology Physicians of Englewood, shares strategies on how to optimize treatment planning for patients with immune thrombocytopenia (ITP).  
Recent Advances in T-Cell Lymphoma: A Conversation with Dr. Steven Horwitz
Keira Smith
Expert Analysis
· In this podcast, Dr. Steven Horwitz of  Memorial Sloan Kettering Cancer Center discusses recent progress in the treatment and management of T-cell lymphoma. Listen now to hear more!
Improving the Management of Metastatic Breast Cancer: A Conversation With Dr. Sara Tolaney
Keira Smith
Podcast
· Keira Smith: Welcome to Oncology Data AdvisorTM, where we explore the latest advances in cancer research and treatment. I'm Keira Smith. In this podcast, Dr. Sara Tolaney from Dana-Farber Cancer Institute will be discussing strategies for improving the management of patients with metastatic breast cancer. Thank you for joining us, Dr. Tola...
Optimizing Treatment Planning for Immune Thrombocytopenia: A Video Interview With Allison Imahiyerobo, APN
Keira Smith
Expert Analysis
Keira Smith: Hi. I'm Keira Smith from Oncology Data Advisor. I'm here today with Allison Imahiyerobo. Allison Imahiyerobo: Hi Keira, my name is Alli Imahiyerobo. I'm a nurse practitioner, and I practice at Hematology Oncology Physicians of Englewood in New Jersey. I focus on both benign and malignant hematology. Keira Smith: What are some of the mo...
The Promising Effects of Patient-Reported Symptom Data on Survival and Well-Being: A Conversation With Dr. Kelly Brassil
Selma Khenissi, MPS
Podcast
Welcome to Oncology Data Advisor, where we explore the latest advances in cancer research and treatment. I am Selma Khenissi from i3 Health. In this podcast, Dr. Kelly Brassil, PhD, RN, from The University of Texas MD Anderson Cancer Center, will be discussing patient-reported symptom data and how it affects patient survival and quality of life. Se...
Recent Advances in T-Cell Lymphoma: A Video Interview With Dr. Steven Horwitz
Keira Smith
Expert Analysis
In this interview, Steven Horwitz, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, speaks with Oncology Data Advisor about the recent advancements in the treatment of T-cell lymphoma. Keira Smith: Hi, I'm Keira Smith from Oncology Data AdvisorTM. I'm here today with Dr. Steven Horwitz. Steven Horwitz, MD: Hi, pleasure ...
Improving the Management of Metastatic Breast Cancer: A Conversation With Dr. Sara Tolaney
Keira Smith
Expert Analysis
Keira Smith: Hi, I'm Keira Smith from Oncology Data AdvisorTM. I'm here today with Dr. Sara Tolaney. Sara Tolaney, MD, MPH: Thanks so much for having me. I'm Sara Tolaney. I'm a breast medical oncologist at Dana-Farber Cancer Institute here in Boston. Keira Smith: Thank you so much for joining us, Dr. Tolaney. So what are some of the most challengi...
Understanding Soft Tissue Sarcoma: Vicki L. Keedy, MD, MSCI, and Brian P. Rubin, MD, PhD
Selma Khenissi, MPS
Expert Analysis
Soft tissue sarcoma is a rare cancer, estimated to be 0.7% of all new cancer cases in 2021. In this excerpt of the transcript from their continuing medical education/nursing continuing professional development (CME/NCPD)-approved activity, Virtual Tumor Board: Optimizing Personalized Care Plans for Patients with Advanced Soft Tissue Sarcoma, V...
The Promising Effects of Patient-Reported Symptom Data on Survival and Well-Being: A Conversation With Dr. Kelly Brassil
Selma Khenissi, MPS
Expert Analysis
  Selma Khenissi, MPS: Hello. Welcome to Oncology Data Advisor, your leading source for oncology news. I am Selma Khenissi from i3 Health. We are here today with Dr. Kelly Brassil, PhD, RN, Advanced Practice Nurse at the University of Texas MD Anderson Cancer Center. She'll be discussing patient-reported symptom data and its positive effect on...
Challenges and New Developments in Metastatic Colorectal Cancer With Tanios Bekaii-Saab, MD
Keira Smith
Expert Analysis
Despite the many obstacles associated with treating and managing patients with metastatic colorectal cancer, the ongoing study of several novel agents has the potential to significantly improve the outcomes of these patients in the coming years. In this interview, Tanios Bekaii-Saab, MD, Professor of Medicine at the Mayo Clinic Cancer Center in Pho...
Exploring Immunotherapy for the Treatment of Merkel Cell Carcinoma: Shailender Bhatia, MD, and Ciara Kelly, MBBCh, BAO
Selma Khenissi, MPS
Expert Analysis
Merkel cell carcinoma is a skin cancer where the Merkel cells grow out of control. In this excerpt of the transcript from their continuing medical education/nursing continuing professional development (CME/NCPD)–approved activity, Update on Immunotherapeutic Strategies for Advanced Merkel Cell Carcinoma, Shailender Bhatia, MD, Associate Professor a...
Identifying Novel Therapies for Multiple Myeloma: Paul Richardson, MD
Elizabeth Heller, PhD
Expert Analysis
In the following interview, Dr. Paul Richardson, the Clinical Program Leader and Director of Clinical Research of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute, discusses some important factors in the development of drugs to target "the queen of immunological cancers," multiple myeloma, and why this disease is diffic...
Personalized Care Plans for Patients With Relapsed/Refractory Follicular Lymphoma: Dr. Loretta J. Nastoupil, MD
Kristin Wright, PharmD
Expert Analysis
Follicular lymphoma is a disease that affects 2.7 per 100,000 individuals each year, with a five-year survival rate of 89.7%. It is the most common subtype of indolent non-Hodgkin's lymphoma; about 22% of newly diagnosed non-Hodgkin lymphoma cases are follicular lymphoma. The development of novel therapies offers new treatment options for patients ...
Exploring Treatment Options for Patients With Renal Cell Carcinoma: Bradley McGregor, MD, and Robert Motzer, MD
Selma Khenissi, MPS
Expert Analysis
In 2021, an estimated 76,080 new cases of kidney cancer will be diagnosed. Among those cases, the majority will be renal cell carcinomas (RCC). In this excerpt of the transcript from their continuing medical education/nursing continuing professional development (CME/NCPD)–approved activity, Expert Guidance on New Advances in Renal Cell Carcinoma, B...
Caring for Patients With Aggressive Non-Hodgkin Lymphoma: Maria R. Badillo, MSN, RN, OCN®, CCRP
Selma Khenissi, MPS
Expert Analysis
Non-Hodgkin lymphoma (NHL) is one of the most common cancers, comprising 4% of all cancers in the United States. Although non-Hodgkin lymphoma can occur at any age, more than half of all patients are 65 years old or older. Efforts are ongoing to find new and better ways to treat non-Hodgkin lymphoma. In this interview, Maria Badillo, MSN, RN, OCN®,...
Treatment Options for Patients with Metastatic Colorectal Cancer: Jaffer A. Ajani, MD
Selma Khenissi, MPS
Expert Analysis
Colorectal cancer is the third leading cause of cancer death among men and women in the United States. Each year, there are 149,500 new cases of colorectal cancer, and 52,980 people die from the disease. Treatment choice depends on many factors, including patient characteristics, tumor characteristics, molecular characteristics, and patient prefere...

Copyright © 2022 Oncology Data Advisor. All rights reserved.